Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Pros and cons of making patients and their families responsible

From: Who should pay for the continuity of post-trial health care treatments?

Patients and Families
Pros Cons
Reduce the final cost of medicines Could limit the access of low-income persons / families
Make the conduction of clinical trials more attractive to sponsors  
Can make patients and families more compliant to treatment